V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200015906 | 200006711 | 0.64 | null | null | 2015-10-08 | 2015-10-09 | VDT-PACE | N | N | 200022979 | ABC-02 TRIAL |
| 200015189 | 200006449 | null | null | Palliative (P) | 2013-09-08 | 2013-09-08 | Bortezomib + Panobinostat | N | null | 200043763 | ABC-02 TRIAL |
| 300004536 | 300003172 | 0 | 104 | Curative (C) | 2018-03-12 | 2018-03-12 | TEMOZOLOMIDE | N | N | 300024268 | ABC-02 TRIAL |
| 280005540 | 280003522 | 1.63 | 93.4 | Palliative (P) | 2017-03-01 | 2017-03-11 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 280029283 | ABC-03 TRIAL |
| 10004060 | 10002563 | 1.57 | null | Palliative (P) | 2019-01-05 | 2019-01-12 | Temozolomide + RT | 2 | N | 10506721 | ABIRATERONE |
| 10006435 | 10004256 | 1.65 | 107.7 | Palliative (P) | 2018-06-06 | 2018-10-25 | Fluorouricil + Folonic Acid (MdG) | N | N | 10427689 | ABIRATERONE |
| 10003556 | 10008102 | 1.66 | 81.8 | Neo-adjuvant (N) | null | 2015-02-26 | EC | N | N | 10482023 | ABIRATERONE |
| 10003575 | 10002270 | 1.7 | 78.4 | Disease modification (D) | 2016-06-15 | 2016-06-23 | Cisplatin + Etoposide (3 day) | 2 | N | 10482879 | ABIRATERONE |
| 10003624 | 10002297 | null | null | Palliative (P) | 2015-12-30 | 2015-12-30 | BCG Intravesical | 02 | N | 10484477 | ABIRATERONE |
| 10003691 | 10002334 | 1.59 | 66.75 | Curative (C) | 2018-04-30 | 2018-04-30 | Bortezomib (weekly) | 2 | Y | 10486352 | ABIRATERONE |
| 10003694 | 10002336 | null | 77.5 | Curative (C) | 2012-12-30 | 2018-02-17 | EC | 2 | N | 10486401 | ABIRATERONE |
| 10003695 | 10002336 | 1.73 | 83 | Palliative (P) | null | 2017-11-08 | CHOP - 21 days | N | N | 10486401 | ABIRATERONE |
| 10003444 | 10002190 | 1.76 | 85 | Disease modification (D) | null | 2015-10-15 | EC | N | N | 10478482 | ABIRATERONE |
| 10003734 | 10002357 | 1.8 | 96.2 | null | 2017-12-05 | 2017-12-05 | Gemcitabine + Capecitabine | 2 | N | 10487591 | ABIRATERONE |
| 10003748 | 10002365 | 1.78 | null | Palliative (P) | 2018-08-15 | 2018-09-10 | CHOP - 14 days | N | Y | 10487962 | ABIRATERONE |
| 10003751 | 10002368 | 1.7 | 75.9 | Adjuvant (A) | 2015-07-20 | 2015-08-07 | Chlorambucil | N | N | 10488040 | ABIRATERONE |
| 10003495 | 10002220 | 1.71 | null | Adjuvant (A) | 2009-11-21 | 2017-10-11 | CTD | 2 | N | 10480234 | ABIRATERONE |
| 10003876 | 10002444 | 1.75 | 103 | Disease modification (D) | 2015-06-12 | 2015-06-12 | Azacitidine | 02 | Y | 10493337 | ABIRATERONE |
| 10003889 | 10002453 | 1.8 | 80.8 | Disease modification (D) | 2016-09-09 | 2016-09-10 | ABVD | 02 | Y | 10494775 | ABIRATERONE |
| 10003902 | 10002459 | 1.57 | 57.9 | null | 2017-12-24 | 2017-12-24 | BCG Intravesical | N | N | 10496480 | ABIRATERONE |
| 10003910 | 10002464 | 1.79 | 65 | Curative (C) | 2018-05-03 | 2018-05-23 | Temozolomide + RT | N | N | 10497700 | ABIRATERONE |
| 10003955 | 10002495 | 1.71 | 89.6 | Curative (C) | 2013-07-04 | 2013-07-04 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10502374 | ABIRATERONE |
| 10003976 | 10002507 | 1.65 | 78.1 | Palliative (P) | 2016-09-06 | 2016-09-26 | Cisplatin | N | N | 10503264 | ABIRATERONE |
| 10004019 | 10002533 | 1.7 | 81.6 | Palliative (P) | 2018-04-05 | 2018-04-12 | Capecitabine + Cisplatin | null | N | 10505302 | ABIRATERONE |
| 10004049 | 10002557 | 1.51 | null | Neo-adjuvant (N) | 2017-08-03 | 2017-08-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10506342 | ABIRATERONE |
| 10003469 | 10002201 | null | 87.599 | Curative (C) | 2014-04-19 | 2014-04-20 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | null | 10479416 | ABIRATERONE |
| 10004086 | 10002581 | null | 59 | Palliative (P) | 2013-08-30 | 2013-09-16 | Capecitabine + Cisplatin | 02 | N | 10507483 | ABIRATERONE |
| 10004091 | 10002586 | 1.55 | 83.5 | Curative (C) | 2018-09-18 | 2018-09-18 | Chlorambucil | N | N | 10507600 | ABIRATERONE |
| 10004152 | 10002623 | 1.54 | 78.9 | Adjuvant (A) | 2018-01-05 | 2018-01-22 | CYCLOPHOSPHAMIDE + EPIRUBICIN | N | N | 10509834 | ABIRATERONE |
| 10004192 | 10002648 | 1.67 | 86 | Palliative (P) | 2016-04-26 | 2016-05-03 | Paclitaxel 7 day | N | N | 10512202 | ABIRATERONE |
| 10004254 | 10002693 | 1.7 | 48 | Adjuvant (A) | 2018-07-02 | 2018-07-22 | ABVD | N | N | 10515485 | ABIRATERONE |
| 10004275 | 10002706 | 1.66 | 69.4 | Palliative (P) | 2016-04-24 | 2016-05-15 | Cisplatin + Etoposide (3 day) | N | N | 10516384 | ABIRATERONE |
| 10004301 | 10002719 | 1.77 | null | Adjuvant (A) | null | 2017-10-13 | Cisplatin + Etoposide (3 day) | N | N | 10517615 | ABIRATERONE |
| 10004312 | 10002726 | 1.62 | 96.9 | Curative (C) | 2017-05-23 | 2017-06-01 | Bortezomib +/- Dexamethasone | 2 | N | 10518110 | ABIRATERONE |
| 10004322 | 10002733 | 1.63 | 124 | Palliative (P) | 2017-05-07 | 2017-05-18 | Cisplatin + Etoposide po&iv 3 day | N | N | 10518885 | ABIRATERONE |
| 10006565 | 10004388 | 1.69 | 127 | Palliative (P) | 2018-06-02 | 2018-06-02 | Pemetrexed | 02 | N | 10437936 | ABIRATERONE |
| 10004356 | 10006629 | 1.6 | 73.2 | Curative (C) | 2017-10-08 | 2017-10-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 10520115 | ABIRATERONE |
| 10006260 | 10007142 | 1.77 | 84.6 | null | 2018-04-15 | 2018-04-16 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10375783 | ABIRATERONE |
| 10006323 | 10004136 | 1.7 | null | Neo-adjuvant (N) | 2017-07-17 | 2017-07-17 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10384069 | ABIRATERONE |
| 10003304 | 10002112 | 1.85 | 71 | Adjuvant (A) | 2015-03-11 | 2015-03-15 | IMATINIB | N | N | 10469047 | ABIRATERONE |
| 10006453 | 10004274 | 1.82 | 123.4 | Curative (C) | 2016-11-26 | 2016-11-26 | GemCarbo Days 1+8 | N | N | 10429043 | ABIRATERONE |
| 10006484 | 10004312 | 1.66 | 99.7 | Neo-adjuvant (N) | 2018-10-08 | 2018-10-10 | Fluorouricil + Folonic Acid (MdG) | 2 | null | 10431261 | ABIRATERONE |
| 10006485 | 10004313 | 1.76 | 67 | Palliative (P) | 2019-05-20 | 2019-05-24 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10431284 | ABIRATERONE |
| 10006531 | 10004352 | 1.79 | 74 | Palliative (P) | 2019-03-09 | 2019-03-16 | Carboplatin + Pemetrexed | N | N | 10435046 | ABIRATERONE |
| 10006536 | 10004358 | 1.8 | null | Disease modification (D) | null | 2018-01-12 | Pemetrexed | 02 | N | 10435635 | ABIRATERONE |
| 10003697 | 10002337 | 1.68 | 90.6 | Palliative (P) | 2017-09-12 | 2017-10-02 | Chlorambucil | N | N | 10486537 | ABIRATERONE |
| 10003487 | 10002214 | 1.6 | 77.4 | Neo-adjuvant (N) | 2017-01-27 | 2017-03-09 | BCG Intravesical | 02 | N | 10480101 | ABIRATERONE |
| 10003473 | 10002204 | 1.71 | null | Neo-adjuvant (N) | 2017-11-30 | 2017-11-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10479742 | ABIRATERONE |
| 10004353 | 10006629 | 1.76 | 48.2 | Disease modification (D) | 2014-01-31 | 2014-02-07 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10520115 | ABIRATERONE |
| 10003753 | 10002370 | 1.73 | 82 | Disease modification (D) | 2016-10-28 | 2016-11-07 | Temozolomide + RT | 02 | null | 10488070 | ABIRATERONE |